TrialJAMA cardiology2022

Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial.

M Cecilia Bahit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.